Compare Boston Scientific Corporation (BSX) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Transocean Ltd — how do they compare? Boston Scientific Corporation trades at $42.94 (market cap $66.37B), while Transocean Ltd trades at $5.27 (market cap $5.88B). The key difference: Boston Scientific Corporation is far larger — about 11.3× Transocean Ltd's market cap, and Transocean Ltd is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | RIG | |
|---|---|---|
Market Cap | $66.37B | $5.88B |
Sector | Health | Technology |
52-Week High | $108.14 | $7.58 |
52-Week Low | $42.63 | $2.55 |
Enterprise Value | $75.94B | $10.82B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
Transocean Ltd. (RIG) trades at $5.37, up 3.27% today, with a bullish technical signal from moving averages. The company reported a net loss of $2.92 billion in 2025, but revenue grew to $3.97 billion, and recent contract wins, including a $1 billion deal with Equinor, bolster its backlog. The pending merger with Valaris Limited aims to reduce leverage and unlock synergies.
The outlook is mixed; analyst consensus is a Buy with a $7.00 price target, but persistent net losses and high debt pose risks. Upside depends on successful merger integration and improved profitability, while oil price volatility and execution challenges remain key concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
